Dermal Penetration of Fentanyl: Inter- and Intraindividual Variations

Pharmacology and Toxicology

Volumn 93, Issue 5, 2003, Pages 244-248

  Larsen, Rikke H ^a   Nielsen, Flemming ^a   Sørensen, Jens A ^b   Nielsen, Jesper B ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL;

ABDOMEN; AQUEOUS SOLUTION; ARTICLE; BREAST; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG PENETRATION; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; SKIN PENETRATION;

ADMINISTRATION, CUTANEOUS; ANALGESICS, OPIOID; FEMALE; FENTANYL; HUMANS; SKIN ABSORPTION;

EID: 0346874446     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-0773.2003.pto930508.x     Document Type: Article

References (26)

1. Bronaugh, R. L. & H. I. Maibach: Percutaneous absorption. Marcel Dekker Inc., USA, 1985.
2. Bronaugh, R. L., R. F. Stewart & M. Simon: Methods for in vitro percutaneous absorption studies. VII: Use of excised human skin. J. Pharm. Sci. 1986, 75, 1094-1097.
3. Cherny, N. J., V. Chang, G. Frager, J. M. Ingham, P. J. Tiseo, B. Popp, R. K. Portenoy & K. M. Foley: Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer 1995, 76, 1283-1293.
4. Collins, J. J., I. J. Dunkel, S. K. Gupta, C. E. Inturrisi, J. Lapin, L. N. Palmer, S. M. Weinstein & R. K. Portenoy: Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates. J. Pediatr. 1999, 134, 319-323.
5. Dellemijn, P. L., H. van Duijn & J. A. Vanneste: Prolonged treatment with transdermal fentanyl in neuropathic pain. J. Pain Symptom. Manage. 1998, 16, 220-229.
6. Egger, C. M., T. Duke, J. Archer & P. H. Cribb: Comparison of plasma fentanyl concentrations by using three transdermal fentanyl patch sizes in dogs. Vet. Surg. 1998, 27, 159-166.
7. Feldmann, R. J. & H. I. Maibach: Regional variation in percutaneous penetration of 14C cortisol in man. J. Invest. Dermatol. 1967, 48, 181-183.
8. Franz, T. J.: Percutaneous absorption on the relevance of in vitro data. J. Invest. Dermatol. 1975, 64, 190-195.
9. Grond, S., L. Radbruch & K. A. Lehmann: Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl. Clin. Pharmacokinet. 2000, 38, 59-89.
10. Guy, R. H., J. Hadgraft & D. A. Bucks: Transdermal drug delivery and cutaneous metabolism. Xenobiotica 1987, 17, 325-343.
11. Jakobsson, M. & P. Strang: Fentanyl patches for the treatment of pain in dying cancer patients. Anticancer Res. 1999, 19, 4441-4442.
12. Lambropoulos, J., G. A. Spanos, N. V. Lazaridis, T. S. Ingallinera & V. K. Rodriguez: Development and validation of an HPLC assay for fentanyl and related substances in fentanyl citrate injection. J. Pharm. Biomed. Anal. 1999, 20, 705-716.
13. McClain, D. A. & C. C. Hug: Intravenous fentanyl kinetics. Clin. Pharmacol. Therap. 1980, 28, 106-114.
14. Nielsen, J. B. & F. Nielsen: Dermal in vitro penetration of methiocarb, paclobutrazol, and pirimicarb. Occup. Environ. Med. 2000, 57, 734-737.
15. Nielsen, J. B.: Effects of four detergents on the in-vitro barrier function of human skin. Int. J. Occup. Environ. Health 2000, 6, 143-147.
16. Reilly, C. S., A. J. Wood & M. Wood: Variability of fentanyl pharmacokinetics in man. Computer predicted plasma concentrations for three intravenous dosage regimens. Anaesthesia 1985, 40, 837-843.
17. Ringe, J. D., H. Faber, O. Bock, S. Valentine, D. Felsenberg, M. Pfeifer, H. W. Minne & S. Schwalen: Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis. Rheumatol. Int. 2002, 22, 199-203.
18. Roberge, R. J., E. P. Krenzelok & R. Mrvos: Transdermal drug delivery system exposure outcomes. J. Emerg. Med. 2000, 18, 147-151.
19. Roy, S. D. & G. L. Flynn: Solubility and related physicochemical properties of narcotic analgesics. Pharm. Res. 1988, 5, 580-586.
20. Roy, S. D. & G. L. Flynn: Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin. Pharm. Res. 1989, 6, 825-832.
21. Roy, S. D. & G. L. Flynn: Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil. Pharm. Res. 1990, 7, 842-847.
22. Roy, S. D., M. Gutierrez, G. L. Flynn & G. W. Cleary: Controlled transdermal delivery of fentanyl: Characterizations of pressure-sensitive adhesives for matrix patch design. J. Pharm. Sci. 1996, 85, 491-495.
23. Roy, S. D., S. Y. Hou, S. L. Witham & G. L. Flynn: Transdermal delivery of narcotic analgesics: comparative metabolism and permeability of human cadaver skin and hairless mouse skin. J. Pharm. Sci. 1994, 83, 1723-1728.
24. Simpson, R. K., E. A. Edmondson, C. F. Constant & C. Collier: Transdermal fentanyl as treatment for chronic low back pain. J. Pain Symptom. Manage. 1997, 14, 218-224.
25. Southwell, D., B. W. Barry & R. Woodford: Variations in permeability of human skin within and between specimens. Int. J. Pharm 1984, 18, 299-309.
26. Varvel, J. R., S. L. Shafer, S. S. Hwang, P. A. Coen & D. R. Stanski, D. R.: Absorption characteristics of transdermally administered fentanyl. Anesthesiology 1989, 70, 928-934.